Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Net Income (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Net Income for 16 consecutive years, with -$31.7 million as the latest value for Q1 2026.

  • For Q1 2026, Net Income fell 254.57% year-over-year to -$31.7 million; the TTM value through Mar 2026 reached $47.4 million, down 64.66%, while the annual FY2025 figure was $99.7 million, 29.43% down from the prior year.
  • Net Income hit -$31.7 million in Q1 2026 for Corcept Therapeutics, down from $24.3 million in the prior quarter.
  • Across five years, Net Income topped out at $47.2 million in Q3 2024 and bottomed at -$31.7 million in Q1 2026.
  • Average Net Income over 5 years is $24.5 million, with a median of $27.5 million recorded in 2023.
  • Year-over-year, Net Income surged 88.85% in 2023 and then tumbled 254.57% in 2026.
  • Corcept Therapeutics' Net Income stood at $16.6 million in 2022, then soared by 88.85% to $31.4 million in 2023, then fell by 1.85% to $30.8 million in 2024, then dropped by 21.08% to $24.3 million in 2025, then tumbled by 230.58% to -$31.7 million in 2026.
  • According to Business Quant data, Net Income over the past three periods came in at -$31.7 million, $24.3 million, and $19.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.